Literature DB >> 809596

Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin.

R Zelis, D T Mason.   

Abstract

To evaluate whether there is cross-tolerance to the circulatory effects of isosorbide dinitrate and nitroglycerin, six subjects were given 120 mg/day of sustained-action isosorbide dinitrate in three divided doses for six to eight weeks. Prior to and during the last week of long-term isosorbide dinitrate administration, the effects of sublingually given nitroglycerin (0.9 mg) on plethysmographically measured calf blood flow and venous volume at 30 mm Hg (VV[30]) were measured on three occasions and averaged. Although the arteriolar dilation produced by nitroglycerin was unaltered by isosorbide dinitrate, the venodilation was significantly attenuated. The VV[30] increased from 3.00 to 3.28 ml/100 ml (P less than .02) with nitroglycerin prior to isosorbide dinitrate administration, but failed to increase with nitroglycerin during the long-term administration of isosorbide dinitrate (2.95 to 2.95 ml/100 ml, P greater than .5).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809596     DOI: 10.1001/jama.234.2.166

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  16 in total

Review 1.  Mechanisms of nitrate tolerance: a review.

Authors:  R J Katz
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 2.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.

Authors:  S Silber; A C Vogler; K H Krause; K Theisen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.

Authors:  J Galle; U Zabel; U Hübner; A Hatzelmann; B Wagner; C Wanner; H H Schmidt
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Characteristics of attenuated endothelium-dependent relaxation seen in rabbit intrapulmonary vein following chronic nitroglycerine administration.

Authors:  Nobuyoshi Kusama; Junko Kajikuri; Yoshimasa Watanabe; Yoshikatsu Suzuki; Hirotada Katsuya; Takeo Itoh
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

Review 7.  Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.

Authors:  U Thadani; T Whitsett
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

8.  Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds.

Authors:  S Fukuyama; Y Hirasawa; D Cox; S Koda; Y Kita
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

Review 9.  Mechanisms of nitrate tolerance.

Authors:  H L Fung; J A Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

Review 10.  Nonresponsiveness to antianginal therapy--a frequent problem?

Authors:  W Schulz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.